RANBAXY RECEIVES APPROVAL TO MARKET DOXYCYCLINE TABLETS

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Doxycycline Tablets 50mg, 75mg and 100mg in the U.S. market.

Yahoo News (http://biz.yahoo.com/prnews/060602/nyf056.html?.v=50)